SMOOTH CLAM

Brand	Owner	Address	Description
SOOTHE & CALM	POLARDREAMS INTERNATIONAL LIMITED	1100 N. 4th Street Fairfield IA 52556	SMOOTH AND CLAM;Bath Beads, Bath Crystals, Bath Foam, Bath Gel, Bath Oil, Bath Pearls, Bath Powder, and non-medicated Bath Salts; Body Cream, Body Glitter, Body Lotion, Body Oil, Body Powder and Body Scrubs; Eye Cream, Eye Gel and Eye Shadow; Face Cream, Face Lotion, Face Mask, Face Powder, Face Toner, Facial Emulsions, Facial Glitter, Facial Scrubs, Blush, Lip Balm, Lip Gloss and Lip Lotion; Hair Conditioner, Hair Gel, Hair Glitter, Hair Mascara and Hair Shampoo; Cuticle Conditioner, Cuticle Cream, Hand Cream, Hand Lotion, Nail Cream and Nail Polish; Antibacterial Soap, Skin Cleansing Creams, Skin Cleansing Lotions, Skin Cream, Skin Lotions, Skin Moisturizers, Skin Soap, Skin Texturizers and Skin Toners; Massage Oil and Essential Oils for personal use; Perfume, Potpourri, or aromatherapy pillows comprising potpourri in fabric containers, or potpourri sachets and Pumice Stone for personal use;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

Arterial and venous smooth muscle cells are molecularly distinct from the earliest stages of angiogenesis through to adulthood. This distinction is revealed by expression on arterial cells (e.g., arterial endothelial cells, arterial smooth muscle cells) of a transmembrane ligand, called EphrinB2 whose receptor EphB4 is expressed on venous cells. Targeted disruption of the EphrinB2 gene prevents the remodeling of veins from a capillary plexus into properly branched structures. Moreover, it also disrupts the remodeling of arteries, suggesting that reciprocal interactions between pre-specified arterial and venous cells are necessary for angiogenesis. Expression of EphrinB2 in arterial cells (e.g., arterial endothelial cells, arterial smooth muscle cells) can be used to advantage in methods for targeting agents and/or encoded polypeptides to arterial smooth muscle cells, altering angiogenesis, assessing the effect of agents on arterial smooth muscle cells, identifying arterial smooth muscle cells, isolating arterial smooth muscle cells and production of artificial vessels, for example.